Clinical trial
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage…
NCT00132639 · Haruhiko Fukuda, Other · Completed
Key facts
| NCT number | NCT00132639 |
|---|---|
| Title | Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Randomized Phase II Study of the Induction Chemotherapy With Docetaxel Alone vs CDDP + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF) |
| Lead sponsor | Haruhiko Fukuda, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Neoplasms |
| Intervention type | Drug |
| Interventions | Preoperative docetaxel-cisplatin combination chemotherapy, Preoperative docetaxel monotherapy |
| Enrollment | 80 |
| Start date | Oct 1, 2002 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Aug 22, 2005 |
| Last update posted | Sep 22, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: